FDA extends comment period for proposed rule to revoke soy protein health claim
The U.S. Food and Drug Administration (FDA) is providing an additional 60 days for public comment on the agency’s proposed rule to revoke the authorized health claim on the relationship between soy protein and reduced risk of coronary heart disease.
Top